Issue · Healthcare

Healthcare (Public Health)

Every healthcare bill, vote, and legislator stance in Oklahoma, automatically classified by Maddy, our AI policy reader.

OK Legislature US Congress

Total bills

2026 Regular Session

Top supporter

Cindy Roe

100% support rate

Top opponent

Molly Jenkins

0% support rate

Ranked legislators

5 support · 5 oppose

Key legislators

Who's moving public health in Oklahoma

Legislators moving public health in Oklahoma
Legislator	Party	Stance	Support rate	Decisive votes
Cindy Roe House · District 42	R	Strong +	100%	15
Aaron Reinhardt Senate · District 37	R	Strong +	100%	14
Bill Coleman Senate · District 10	R	Strong +	100%	14
Danny Sterling House · District 27	R	Strong +	100%	14
John Haste Senate · District 36	R	Strong +	100%	14
Molly Jenkins House · District 33	R	Strong −	0%	13
Tom Gann House · District 8	R	Strong −	0%	12
Rick West House · District 3	R	Strong −	8%	12
Rob Hall House · District 67	R	Strong −	9%	11
Kendal Sacchieri Senate · District 43	R	Strong −	11%	9

Showing 11–11 of 11 bills

All healthcare bills

in committee · Oklahoma · Senate Feb 4, 2025

SB 771: Advertising; prohibiting certain direct-to-consumer advertising by pharmaceutical companies; creating felony offense. Effective date. Emergency.

SB 771 prohibits Oklahoma pharmaceutical companies from advertising prescription drugs directly to consumers through any medium (TV, digital, print, social media, etc.). Violating this ban would be a felony punishable by up to $500,000 in fines or five years in prison per offense. The bill includes exceptions for doctor-patient educational materials, public health campaigns, clinical trial promotions, and insurance coverage information - provided they don’t promote specific drugs. It takes effect July 1, 2025, and aims to align Oklahoma with global norms that restrict such advertising.

Topics ✗ Healthcare

Sub-Topics Insurance Public Health